It is well known that more than 90% of patients with CMML have somatic mutations, with splicing factor mutations such as SRSF2, U2AF1, ZRSR2 and SF3B1 being highly prevalent, especially SRSF2 (20–24). This evidence concerns the gene SRSF2 and chronic myelomonocytic leukemia.